The FDA has approved voice-guided epinephrine injection device (Auvi-Q) for treatment of severe allergic reactions

0

Intravenous products: Medpage Today report “The FDA has approved the first voice-guided epinephrine injection device (Auvi-Q) for treatment of severe allergic reactions. The device, which gives verbal step-by-step instructions, can be used by children weighing at least 33 pounds who are at risk for, or have a history of, anaphylaxis. Developed by Sanofi US, the Auvi-Q 0.15 mg/0.3 mg auto-injector comes in a rectangular box that is roughly the size of a credit card, and guides a user through the injection process with audio-visual instructions as well as or written directions. Most epinephrine autoinjectors are in a wand-like form.”

Click here for the full story.

Main page

Share.

Comments are closed.